AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Research and Development Expense (Annual): 1.025M for Dec. 31, 2022
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 1.025M |
| December 31, 2021 | 1.456M |
| December 31, 2020 | 3.714M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.904M |
| December 31, 2018 | 6.63M |
| December 31, 2017 | 5.784M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.025M
Minimum
2022
5.904M
Maximum
2019
3.025M
Average
2.585M
Median
Research and Development Expense (Annual) Benchmarks
| Homology Medicines Inc (DELISTED) | 62.00M |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.63M |
| iBio Inc | 10.33M |
| Theriva Biologics Inc | 14.31M |